Free Trial

Genus (GNS) Competitors

Genus logo
GBX 1,776 +22.00 (+1.25%)
As of 02/21/2025 11:46 AM Eastern

GNS vs. HWDN, DPH, IGG, CTY, SMWH, CAR, PRP, AUK, BAY, and STG

Should you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), Bay Capital (BAY), and Strip Tinning (STG). These companies are all part of the "personal services" industry.

Genus vs.

Howden Joinery Group (LON:HWDN) and Genus (LON:GNS) are both consumer cyclical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and valuation.

70.6% of Howden Joinery Group shares are held by institutional investors. Comparatively, 77.8% of Genus shares are held by institutional investors. 0.5% of Howden Joinery Group shares are held by insiders. Comparatively, 0.8% of Genus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Howden Joinery Group received 316 more outperform votes than Genus when rated by MarketBeat users. Likewise, 72.37% of users gave Howden Joinery Group an outperform vote while only 70.54% of users gave Genus an outperform vote.

CompanyUnderperformOutperform
Howden Joinery GroupOutperform Votes
668
72.37%
Underperform Votes
255
27.63%
GenusOutperform Votes
352
70.54%
Underperform Votes
147
29.46%

Howden Joinery Group pays an annual dividend of GBX 21 per share and has a dividend yield of 2.5%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.8%. Howden Joinery Group pays out 45.0% of its earnings in the form of a dividend. Genus pays out 265.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Howden Joinery Group had 3 more articles in the media than Genus. MarketBeat recorded 4 mentions for Howden Joinery Group and 1 mentions for Genus. Howden Joinery Group's average media sentiment score of 1.13 beat Genus' score of 0.67 indicating that Howden Joinery Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Howden Joinery Group
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genus
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Howden Joinery Group presently has a consensus price target of GBX 951.50, indicating a potential upside of 12.60%. Genus has a consensus price target of GBX 2,150, indicating a potential upside of 21.06%. Given Genus' stronger consensus rating and higher possible upside, analysts plainly believe Genus is more favorable than Howden Joinery Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Howden Joinery Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Genus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Howden Joinery Group has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Genus has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500.

Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
Howden Joinery Group10.82% 25.70% 10.70%
Genus 1.18%1.41%3.31%

Howden Joinery Group has higher revenue and earnings than Genus. Howden Joinery Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Howden Joinery Group£2.34B1.97£253.42M£46.6518.11
Genus£666.67M1.74£7.87M£12.06147.21

Summary

Howden Joinery Group beats Genus on 15 of the 20 factors compared between the two stocks.

Get Genus News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNS vs. The Competition

MetricGenusBiotechnology IndustryMedical SectorLON Exchange
Market Cap£1.16B£117.96M£5.84B£2.63B
Dividend Yield1.69%3.69%4.75%4.98%
P/E Ratio147.213.2025.47163.46
Price / Sales1.744,826.69447.58312,330.40
Price / Cash50.5613.0138.0128.04
Price / Book2.1547.077.645.15
Net Income£7.87M-£87.82M£3.18B£5.73B
7 Day Performance-4.93%0.29%-1.99%-0.99%
1 Month Performance0.34%3.57%-0.42%-0.80%
1 Year Performance-9.66%99.10%16.51%39.35%

Genus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNS
Genus
1.3739 of 5 stars
GBX 1,776
+1.3%
GBX 2,150
+21.1%
-7.1%£1.16B£666.67M147.21480Gap Down
HWDN
Howden Joinery Group
2.7803 of 5 stars
GBX 845
-1.1%
GBX 951.50
+12.6%
+6.0%£4.61B£2.34B18.1112,000News Coverage
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50M-15,464.002,457News Coverage
IGG
IG Group
1.4961 of 5 stars
GBX 962.50
-0.5%
GBX 982.33
+2.1%
+36.2%£3.41B£913.00M6.422,754News Coverage
CTY
City of London
N/AGBX 443
+0.7%
N/A+10.8%£2.19B£307.08M7.46N/ADividend Announcement
SMWH
WH Smith
N/AGBX 1,234
+0.9%
GBX 1,456.67
+18.0%
-9.5%£1.59B£1.83B25.4614,935Dividend Increase
CAR
Carclo
N/AGBX 21.40
-7.8%
N/A+169.3%£15.71M£132.66M-4.761,059Gap Down
High Trading Volume
PRP
Prime People
N/AN/AN/AN/A£8.15M£19.72M10.9813,100Gap Down
AUK
Aukett Swanke Group
N/AGBX 1.52
-5.3%
N/A+26.3%£5.46M£23.61M-6.3232,200Gap Down
BAY
Bay Capital
N/AGBX 7.75
flat
N/AN/A£5.43MN/A-3.832
STG
Strip Tinning
N/AGBX 25
-10.7%
N/A-36.3%£4.56M£10.09M-1.524,060High Trading Volume

Related Companies and Tools


This page (LON:GNS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners